Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 22972090)

Published in Cochrane Database Syst Rev on September 12, 2012

Authors

Chirag G Patil1, Katie Pricola, J Manuel Sarmiento, Sachin K Garg, Andrew Bryant, Keith L Black

Author Affiliations

1: Department ofNeurosurgery,MaxineDunitz Neurosurgical Institute, Los Angeles, CA,USA. chiragpatil@gmail.com.

Articles citing this

Stereotactic radiosurgery (SRS) for brain metastases: a systematic review. Radiat Oncol (2014) 1.24

Stereotactic radiosurgery for single brain metastases from non-small cell lung cancer: progression of extracranial disease correlates with distant intracranial failure. Radiat Oncol (2013) 0.95

Dural metastases in advanced prostate cancer: a case report and review of the literature. Curr Urol (2014) 0.92

Oligometastatic breast cancer: a shift from palliative to potentially curative treatment? Breast Care (Basel) (2014) 0.91

Ionizing radiation promotes the acquisition of a senescence-associated secretory phenotype and impairs angiogenic capacity in cerebromicrovascular endothelial cells: role of increased DNA damage and decreased DNA repair capacity in microvascular radiosensitivity. J Gerontol A Biol Sci Med Sci (2013) 0.89

Gamma knife treatment of brainstem metastases. Int J Mol Sci (2014) 0.85

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2014) 0.85

Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis. Med Oncol (2016) 0.81

Non-small cell lung cancer therapy: safety and efficacy in the elderly. Drug Healthc Patient Saf (2013) 0.77

Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis. Biomed Res Int (2016) 0.76

Cerebromicrovascular dysfunction predicts cognitive decline and gait abnormalities in a mouse model of whole brain irradiation-induced accelerated brain senescence. Geroscience (2017) 0.75

Survival was Significantly Better with Surgical/Medical/Radiation Co-interventions in a Single-Institution Practice Audit of Frameless Stereotactic Radiosurgery. Cureus (2016) 0.75

Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer. Contemp Oncol (Pozn) (2016) 0.75

Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases. Int J Mol Sci (2016) 0.75

Central nervous system metastasis from breast cancer. Oncologist (2014) 0.75

First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases. Cancer Med (2017) 0.75

Survival patterns of 5750 SRS-treated brain metastasis patients as a function of the number of lesions. World Neurosurg (2017) 0.75

Articles by these authors

The somatic genomic landscape of glioblastoma. Cell (2013) 11.73

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer (2006) 8.50

Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene (2004) 4.29

Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ (2004) 3.66

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res (2004) 2.89

Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tob Res (2003) 2.62

Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients. Cancer Res (2008) 2.12

Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM). Oncogene (2005) 2.06

Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected]. Proc Natl Acad Sci U S A (2010) 2.05

The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res (2002) 1.85

Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res (2002) 1.72

Centralisation of services for gynaecological cancer. Cochrane Database Syst Rev (2012) 1.67

Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage (2010) 1.59

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clin Cancer Res (2004) 1.57

Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia (2004) 1.56

Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev (2011) 1.56

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma. Cancer Immunol Immunother (2012) 1.54

High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray. Mol Cancer Res (2009) 1.53

Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells (2007) 1.53

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo. Clin Cancer Res (2007) 1.53

Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery. Bioconjug Chem (2006) 1.51

Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev (2011) 1.50

Generation of neural progenitor cells from whole adult bone marrow. Exp Neurol (2002) 1.49

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells (2009) 1.47

Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Cancer Res (2006) 1.42

Diagnosis of meningioma by time-resolved fluorescence spectroscopy. J Biomed Opt (2006) 1.36

Infratentorial supracerebellar resection of a pineal tumor using a high definition video exoscope (VITOM®). J Clin Neurosci (2011) 1.27

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Cancer Res (2004) 1.26

Nanoconjugate based on polymalic acid for tumor targeting. Chem Biol Interact (2007) 1.22

Fluorescence lifetime spectroscopy of glioblastoma multiforme. Photochem Photobiol (2004) 1.20

Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res (2006) 1.19

Association between laminin-8 and glial tumor grade, recurrence, and patient survival. Cancer (2004) 1.18

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma. J Immunol (2004) 1.17

Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity. Cancer Res (2011) 1.16

Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis. Angiogenesis (2006) 1.15

Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid). Pharm Res (2010) 1.13

Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid). J Control Release (2007) 1.13

Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev (2010) 1.13

Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model. Cancer Res (2003) 1.12

Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast Cancer Res (2005) 1.12

Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas. Stem Cells (2008) 1.11

Development of an intracranial ependymoma at the site of a pre-existing cavernous malformation. Surg Neurol (2003) 1.10

Thymic CD8+ T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality. J Immunol (2003) 1.10

Palliative surgery versus medical management for bowel obstruction in ovarian cancer. Cochrane Database Syst Rev (2010) 1.10

Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy. Oncogene (2005) 1.08

Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database Syst Rev (2011) 1.08

Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev (2010) 1.08

Everolimus for astrocytomas in tuberous sclerosis. Lancet (2013) 1.07

Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment. Neurodegener Dis (2012) 1.06

Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro. Mol Cancer Ther (2003) 1.06

Surgical cytoreduction for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev (2013) 1.04

Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery. Nanomedicine (Lond) (2008) 1.04

Intraoperative delineation of primary brain tumors using time-resolved fluorescence spectroscopy. J Biomed Opt (2010) 1.04

Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas. J Neurooncol (2003) 1.04

Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. Int J Cancer (2010) 1.04

Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. Cochrane Database Syst Rev (2013) 1.03

Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels. J Pharmacol Exp Ther (2002) 1.03

Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid). Int J Mol Sci (2012) 1.02

Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J Neurochem (2009) 1.02

Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev (2012) 1.02

Radiotherapy and chemoradiation after surgery for early cervical cancer. Cochrane Database Syst Rev (2012) 1.01

Angiogenesis inhibitors for the treatment of ovarian cancer. Cochrane Database Syst Rev (2011) 1.01

Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme. Int J Cancer (2008) 1.00

AIM-2: a novel tumor antigen is expressed and presented by human glioma cells. J Immunother (2004) 1.00

Adjuvant chemotherapy for advanced endometrial cancer. Cochrane Database Syst Rev (2014) 0.99

Fluorescence lifetime spectroscopy for guided therapy of brain tumors. Neuroimage (2010) 0.99

Interventions for the treatment of Paget's disease of the vulva. Cochrane Database Syst Rev (2013) 0.99

DCVax-Brain and DC vaccines in the treatment of GBM. Expert Opin Investig Drugs (2009) 0.98

A high-definition exoscope system for neurosurgery and other microsurgical disciplines: preliminary report. Surg Innov (2008) 0.97

Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma. J Immunother (2003) 0.97

Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer. Cochrane Database Syst Rev (2013) 0.97

Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era. PLoS One (2012) 0.97

Hormonal therapy in advanced or recurrent endometrial cancer. Cochrane Database Syst Rev (2010) 0.97

Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst Rev (2011) 0.97

Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response. Eur J Immunol (2004) 0.96

Prognosis of patients with multifocal glioblastoma: a case-control study. J Neurosurg (2012) 0.95

Long-term survival in a child with a central nervous system medulloepithelioma. J Neurosurg Pediatr (2008) 0.95

Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage (2010) 0.95

Survival and prognostic factors of anaplastic gliomas. Neurosurgery (2013) 0.95

Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer. PLoS One (2012) 0.95

Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev (2013) 0.94

Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase. Cancer Res (2008) 0.94

Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev (2015) 0.93

Centralisation of services for gynaecological cancers - a Cochrane systematic review. Gynecol Oncol (2012) 0.92

Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials. Cancer Control (2004) 0.92

Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in rats. J Immunother (2003) 0.92

The effect of centralization of caseload for primary brain tumor surgeries: trends from 2001-2007. Acta Neurochir (Wien) (2012) 0.91

Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. Cochrane Database Syst Rev (2011) 0.91

Tamoxifen for relapse of ovarian cancer. Cochrane Database Syst Rev (2010) 0.91

Red blood cell docosahexaenoic acid and eicosapentaenoic acid concentrations are positively associated with socioeconomic status in patients with established coronary artery disease: data from the Heart and Soul Study. J Nutr (2008) 0.91

Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev (2011) 0.91

Measurement of blood-brain and blood-tumor barrier permeabilities with [14C]-labeled tracers. Methods Mol Med (2003) 0.90

A herpes simplex virus type 1 mutant with gamma 34.5 and LAT deletions effectively oncolyses human U87 glioblastomas in nude mice. Neurosurgery (2002) 0.90

Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity. J Immunol (2004) 0.90

Association between omega-3 fatty acids and depressive symptoms among patients with established coronary artery disease: data from the Heart and Soul Study. Psychother Psychosom (2009) 0.89

The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery. Biomaterials (2011) 0.89

Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer. Cancer Gene Ther (2002) 0.89

Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier. Drug News Perspect (2003) 0.89

Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline. J Clin Invest (2014) 0.89